“Cognitive enhancement drugs only have short-term benefits and can cause significant side-effects for people with mild memory problems, according to researchers. In a new review of existing data, researchers at St. Michael’s Hospital in Toronto, Canada studied eight randomized clinical trials and three companion reports on the efficacy of four drugs in people with mild cognitive impairment. The drugs were donepezil (Aricept), rivastigmine (Exelon), galantamine (Razadyne), and memantine (Namenda). They found that while the drugs do have short-term benefits, they are lost after a year and a half of treatment.”
Did you like this?
Tip Freedomwat.ch Staff with Bitcoin
Tip Freedomwat.ch Staff with Bitcoin
Related posts:
US poverty rate steady at 15 percent, but 'lower class' is booming
Where Bank Regulators Go to Get Rich
Politics leads to cancellation of only U.S. medical marijuana study
D.C. Mayor Proposes More Speed Cameras to Balance Budget
Australian Government to establish bank bailout fund with new levy
Toronto Reviews Bid to Become Yuan Currency Trading Hub
Indian government seeks gold purchase information from jewellers
North Korean spy’s memoir details ‘enemization’ training by abducted South Koreans
Jesse Kline: Behold the power of Bitcoin
Gibson Is Off the Feds' Hook. Who's Next?
Bitcoin market price app, 'Bitcoin Alarm,' is carefully cloaked malware
Associated Press CEO: Sources will no longer speak to us because of phone monitoring
Leszek Balcerowicz: The Anti-Bernanke
Justin Amash vs Former NSA Head General Michael Hayden 8/4/13
Dutch King tells citizens ‘to take responsibility’ as austerity implemented